Free Trial
OTCMKTS:LHDXQ

Lucira Health (LHDXQ) Stock Price, News & Analysis

Lucira Health logo
$0.0001 +0.00 (+∞)
As of 10/4/2023

About Lucira Health Stock (OTCMKTS:LHDXQ)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
$1.45
Volume
20,900 shs
Average Volume
7.18 million shs
Market Capitalization
$4,060.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive LHDXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter.

LHDXQ Stock News Headlines

The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
Best Senior Dating Sites Of 2023
8-K: Lucira Health, Inc.
See More Headlines

LHDXQ Stock Analysis - Frequently Asked Questions

Lucira Health's stock was trading at $0.0001 at the beginning of the year. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Lucira Health, Inc. (OTCMKTS:LHDXQ) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $0.04. The business earned $14.98 million during the quarter, compared to analysts' expectations of $18 million.

Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/11/2021
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
OTCMKTS:LHDXQ
Fax
N/A
Employees
221
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$93.06 million
Price / Cash Flow
N/A
Book Value
$4.81 per share
Price / Book
0.00

Miscellaneous

Free Float
28,257,000
Market Cap
$4,060.00
Optionable
Not Optionable
Beta
2.60
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:LHDXQ) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners